These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Houlihan HH; Mercier RC; Rybak MJ Antimicrob Agents Chemother; 1997 Nov; 41(11):2497-501. PubMed ID: 9371356 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis. Gavaldà J; López P; Martín T; Gomis X; Ramírez JL; Azuaje C; Almirante B; Pahissa A Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345 [TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target. Andes D; Craig WA Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855 [TBL] [Abstract][Full Text] [Related]
30. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of fosfomycin-penicillin M and penicillin M-gentamycin. Apropos of 35 severe infections caused by methicillin-sensitive Staphylococcus aureus]. Baron D; Touze MD; Tasseau F; Reynaud A; Derriennic M; Courtieu AL Rev Med Interne; 1987; 8(1):109-14. PubMed ID: 3645705 [TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model. Huang V; Rybak MJ Antimicrob Agents Chemother; 2005 Jan; 49(1):302-8. PubMed ID: 15616309 [TBL] [Abstract][Full Text] [Related]
33. Causes and Implications of the Disappearance of Rifampin Resistance in a Rat Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis. Brinkman CL; Tyner HL; Schmidt-Malan SM; Mandrekar JN; Patel R Antimicrob Agents Chemother; 2015 Aug; 59(8):4481-8. PubMed ID: 25987614 [TBL] [Abstract][Full Text] [Related]
34. Drug resistance pattern of methicillin resistant Staphylococcus aureus. Pal N; Ayyagari A Indian Pediatr; 1991 Jul; 28(7):725-9. PubMed ID: 1800344 [TBL] [Abstract][Full Text] [Related]
35. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis. Eng RH; Cherubin CE; Smith SM; Buccini F; Harris R J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis. Domínguez-Herrera J; López-Rojas R; Smani Y; Labrador-Herrera G; Pachón J Int J Antimicrob Agents; 2016 Dec; 48(6):661-665. PubMed ID: 28128094 [TBL] [Abstract][Full Text] [Related]
37. Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies. Foster JK; Lentino JR; Strodtman R; DiVincenzo C Antimicrob Agents Chemother; 1986 Dec; 30(6):823-7. PubMed ID: 3643771 [TBL] [Abstract][Full Text] [Related]
38. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. Chuard C; Lucet JC; Rohner P; Herrmann M; Auckenthaler R; Waldvogel FA; Lew DP J Infect Dis; 1991 Jun; 163(6):1369-73. PubMed ID: 1903801 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections. Hirschl A; Stanek G; Rotter M J Antimicrob Chemother; 1984 May; 13(5):429-35. PubMed ID: 6735962 [TBL] [Abstract][Full Text] [Related]